HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches

0 Views
administrator
administrator
07/03/23

Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next